Summary of Cronos Group Q4 2025 Earnings Call

1Key Financial Results and Metrics

Q4 2025 Net Revenue: $44.5 million, a 47% increase year-over-year.

Full Year 2025 Net Revenue: Record levels achieved, with organic growth of 25%.

Gross Profit: $16.2 million in Q4, equating to a 36% margin, up from 30% in Q4 2024.

Adjusted EBITDA: $0.5 million in Q4, an improvement of $7.7 million year-over-year, but lower than the first three quarters of 2025.

Cash Position: Ended Q4 with $832 million in cash and equivalents, up $8 million from Q3 2025.

2Strategic Updates and Business Highlights

Product Performance: Strong sales from flower, vapes, and edibles, particularly the Spinach brand, which became the second-most popular brand in Canada.

Innovation: Launched Spinach Puffers, an all-in-one vape device, and continued to expand edibles with successful new products.

International Growth: Significant revenue growth in Israel (52% year-over-year) and other international markets (68% year-over-year), with PEACE NATURALS leading in Israel.

Acquisition Announcement: Entered a definitive agreement to acquire CanAdelaar for approximately $67.5 million, enhancing presence in the Netherlands' adult-use cannabis market.

3Forward Guidance and Outlook

2026 Expectations: Anticipate continued growth driven by increased production capacity from GrowCo's expansion and the closing of the CanAdelaar acquisition.

Gross Margin Outlook: Expected to stabilize around 43%, with potential for future expansion, particularly from the CanAdelaar acquisition.

4Challenges and Points of Concern

Production Constraints: Supply constraints limited growth potential in the flower category, although expected to ease in 2026.

Gross Margin Pressures: Q4 margins were impacted by production quality issues during GrowCo's ramp-up and expense timing, leading to lower margins compared to earlier quarters.

Regulatory Uncertainty: Ongoing regulatory challenges in international markets, particularly in Germany, may affect strategic decisions.

5Notable Q&A Insights

Product Allocation: Management indicated that with increased supply from GrowCo, they will be able to better allocate products in Canada and expand aggressively in Europe.

Future Gross Margins: Management clarified that while they expect margins to stabilize, the CanAdelaar acquisition could provide additional upside.

Market Strategy: Emphasized a disciplined approach to M&A, focusing on opportunities that align with their borderless product strategy and brand expansion.

Long-term View on Acquisitions: Management expressed caution about acquiring downstream assets, preferring to remain flexible and responsive to market conditions. Overall, Cronos Group reported strong financial performance in Q4 2025, driven by robust demand and strategic initiatives, while also acknowledging challenges related to production and regulatory environments. The outlook for 2026 appears positive, with expectations for continued growth and margin stabilization.